PHIO Q1 2019 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena

PHIOPhio Pharmaceuticals Corp.

$13M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$21,000-8.7% YoY

Gross Profit

-$1M-5085.7% margin

Operating Income

-$2M-10219.0% margin

Net Income

-$2M-10090.5% margin

EPS (Diluted)

$-617.04

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$160,000

Balance Sheet

Total Assets

$14M

Total Liabilities

$2M

Stockholders' Equity

$12M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21,000	$23,000	-8.7%
Gross Profit	-$1M	-$1M	+20.2%
Operating Income	-$2M	-$2M	+4.2%
Net Income	-$2M	-$2M	+5.4%